Lv12
30 积分 2025-07-18 加入
Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy
1小时前
待确认
Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy with glyco-optimization and immune checkpoint blockade
18小时前
已完结
Aptamer‐based Immune Checkpoint Inhibition for Cancer Immunotherapy
1个月前
已完结
Siglecs: From Biomodulation to Immunotherapy
1个月前
已完结
Erythromycin Repurposing for Hepatocellular Carcinoma Treatment: Targeting CD24 to Enhance Anti-Tumor Immunity
2个月前
已完结
Role and regulation mechanism of Gal-3 in non-small cell lung cancer and its potential clinical therapeutic significance
2个月前
已完结
皖公网安备34019202002308
